A total of 1 813 batches of clinical serum and drug were tested in this research. Thirty-one clinically healthy serum were used; ceftazidime for Injection (Qilu Pharmaceutical Co., Ltd. China), tryptophan (Sigma-Aldrich Co. USA) a total of 130 species medicine were used.
BET is a canonical method of bacterial endotoxins test, that is widely used for clinical application and drug control. BET is easy to be interfered in the daily detection. The presence of endotoxin in a product may be masked by factors interfering with the reaction between the endotoxins and the amoebocyte lysate. Thus the purpose of the interference test is to determine which concentration or how much dilution of the sample does not interfere the reaction between endotoxins and LAL reagent. This provides the basis to determine whether bacterial endotoxins inspection method could be used. In China, nearly 8 million bottles of limulus reagents are used in a year. Since Limuloid resources in China are getting exhausted, we hereby bring out five new interference methods to minimize the application of LAL with a precondition of assured quality. We spontaneously ran 1 813 batches of samples by new methods and canonical methods and compared the differences of pass rate via SAS software to evaluate the consistency and differences among the methods.
Test for interfering factors
According to the bacterial endotoxins interfering factors tests in USP36 <85>, bacterial endotoxins test (Table 1) 
Statistical analysis
We analyzed the data in Table 3 using χ 2 test. Moreover, we analyzed the data in Table 4 (2×2 table) by kappa coefficient and Bowker's test for symmetry to compare the consistency and difference of results judged by USP36 and new models. The diagnostic parameters such as sensitivity (Se), specificity (Sp), agreement rate (π), Youden index (YI), were also calculated by using the results of USP36 as the reference standard .
RESULTS
Test results of the original data for 1 813 samples determined by USP36, models 1, 2, 3, 4, 5 are shown in Tables 3 and 4 . The analyzed results are shown in Table 5 .
DISCUSSION
According to the test results of the original data for 1 813 samples determined by USP36, models 1, 2, 3, 4, and 5 (Table 3 ), we can conclude that all the new and canonical methods reach 89.5%−90.7% pass rate within relatively good consistency with each other. By analyzing Table 4 , we found that the results of USP36 and model 3, models 1 and 4, models 2 and 5 are the same, respectively, which indicates that the result of replicates of 1λ and 0.5λ in Solution B has no effect on the conclusions of the test.
On the other hand, model 1 and 4, gave out controversial results with USP method in 15 batches (0.83%) of samples, which let the 15 batches of samples pass by mistake. In addition to this, model 25 has different results in 21 batches (1.16%) of samples with US, and the results show false pass as well. Despite these differences, the consistency can be considered as good. Further evaluation of the existence of significant differences need more advanced data investigation on statistical analysis.
According to the results of statistical analysis, the Sp value of all new models is 100%. This indicates that mistakes did not occur during diagnosis. Models 3, 4 and 5 are simpler than USP36, models 1 and 2 individually. The P-value of χ 2 test of all new models indicates that there is no significant difference between USP36 and all new models. Kappa value indicates 3 that the consistency between USP36 and all new models as index of Se, YI and π, USP36 (model 3) >model 4 (model 1) >model 5 (model 2). This indicates that the most simple method causes lower sensitivity. P-value of the McNemar's test indicate that there is no significant difference between the USP36 (model 3) and Model 4 (model 1). USP36 (model 3) is stricter than model 5 (model 2).
If the new methods suggested by us are applied, the amount of limulus reagent could be significantly reduced in the preparation of test solutions for interfering factors, USP36 (30 vial) >model 1 (24 vial) >model 2 (20 vial) >model 3 (16 vial) >model 4 (14 vial) >model 5 (12 vial), which is consistent with the 3R (Reduction, Refinement, and Replacement) principle of animal test. 4, 5 In conclusion, all the five simple new models suggested above are feasible for interfering factors test in the Bacterial Endotoxins test. After comprehensive consideration, we recommend model 4 as a reference for the revision of Pharmacopoeia for its agent saving ability without reducing sensitivity.
